Ryanair May Look Beyond Boeing Amid Tariff Concerns

Published 1 hours agoBA

Ryanair May Look Beyond Boeing Amid Tariff Concerns

Ryanair CEO Michael O'Leary has indicated that the airline might explore alternatives to Boeing for its aircraft orders if U.S. tariffs significantly drive up costs. This development comes as Ryanair is completing its order of 210 Boeing 737 MAX jets, with 29 planes still expected by March of next year, according to Reuters.

In addition to their current order, Ryanair holds 150 firm orders for the Boeing MAX 10 model, with options for 150 more, starting in 2027. Concerns have been raised about potential increases in aircraft prices due to U.S. tariffs, pushing Ryanair to consider other manufacturers. O'Leary mentioned that they haven't discussed with Chinese manufacturer COMAC since 2011, but would consider them if their planes were priced 10%-20% lower than those of Boeing's competitor Airbus.

U.S. Representative Raja Krishnamoorthi has voiced concerns over the possibility of Ryanair purchasing Chinese-manufactured planes, citing potential national security risks. Meanwhile, Boeing is actively working to address Ryanair's concerns, focusing on improving the quality and delivery performance of the 737 model, as reported by Aeroxplorer.

Share this article

Twitter Facebook LinkedIn

Recent Articles

GM Lowers 2025 Profit Forecast Due to Tariff Concerns

GM Lowers 2025 Profit Forecast Due to Tariff Concerns

11 minutes agoGM

General Motors has cut its 2025 profit forecast, citing the hefty financial burden of newly adjusted automotive tariffs. The company now predicts an annual adjusted core profit in the range of $10 billion to $12.5 billion, a significant drop from initial forecasts of $13.7 billion to $15.7 billion. With expected tariff-related costs ranging from $4 billion to $5 billion, the revised numbers reflect a tough market environment. Reuters reported these newly imposed tariffs are complicating financial projections for several major automakers. Alongside the decline in profit forecast, GM has also adjusted its net income estimates. The automaker expects to see an annual net income between $8.2 billion and $10.1 billion, reduced from earlier projections of $11.2 billion to $12.5 billion. The ripple effects of U.S. President Donald Trump's evolving trade policies and a steep 25% tariff on imported vehicles have even led companies like Stellantis and Mercedes-Benz to withdraw their profit forecasts altogether. CEO Mary Barra addressed these challenges, emphasizing GM's ongoing dialogue with the Trump administration and international trade partners to manage these policy shifts. Despite these efforts, GM's stock took a hit amidst investor worries over the updated financial outlook.

Moderna Posts Q1 2025 Loss on Plummeting Vaccine Sales

Moderna Posts Q1 2025 Loss on Plummeting Vaccine Sales

26 minutes agoMRNA

Moderna reported a first-quarter 2025 net loss of $1.18 billion, translating to a loss of $3.07 per share. This decline was accompanied by revenue figures of $167 million, a sharp fall from the $1.86 billion recorded in the same quarter the previous year. NBC New York noted these results reflected weaker demand for its COVID-19 vaccine during the period. The steep decline in COVID-19 vaccine sales—down about 90% from the previous year—primarily drove the revenue decrease. Additionally, the sales for Moderna's respiratory syncytial virus vaccine, mRESVIA, did not meet expectations, according to Reuters. These challenges highlight the hurdles Moderna faces as it adjusts to diminishing demand in its core product areas. In response to these challenges, Moderna has enacted cost-cutting strategies aimed at reducing adjusted operating costs by $1.7 billion by 2027, with a plan to trim down cash costs by $1 billion in 2025. Despite the current struggles, the company maintains its full-year revenue projection of $1.5 to $2.5 billion, anticipating increased demand later in the year. Additionally, Moderna is preparing for a potential U.S. regulatory approval of a combination COVID-19 and flu vaccine by 2026, indicating efforts towards product diversification.

Allstate's Q1 Profit Drops 52% Amid Rising Catastrophe Losses

Allstate's Q1 Profit Drops 52% Amid Rising Catastrophe Losses

41 minutes agoALL

Allstate Corporation reported a significant decline in its first-quarter net profit for 2025, with numbers showing a sharp 52.4% decrease. The company's net profit fell to $566 million, equating to $2.11 per share, from $1.19 billion, or $4.46 per share, during the same period the previous year. Reuters highlighted this downturn is largely attributed to catastrophic events inflating losses in its homeowner's insurance segment. The company's catastrophe losses soared to $2.22 billion, up from $731 million the previous year, notably due to California wildfires and wind events in March. Homeowner's insurance suffered especially hard, with losses more than triple last year’s figures, reaching $1.8 billion. Despite these challenges, Allstate's auto insurance segment exhibited robust performance, with an improved underlying combined ratio, moving from 86.9% to an impressive 83.1%, reflecting stronger underwriting profitability. Revenue for Allstate increased by 7.8%, reaching $16.45 billion, thanks to higher average premiums and policy upticks. Net investment income also saw a rise, climbing to $854 million from the previous year's $764 million, aiding profitability. However, stringent insurance regulations in California are restricting Allstate's pricing flexibility, posing additional challenges in adjusting premiums to meet rising risk levels, as per reports from Reuters. These issues highlight the company's ongoing efforts to navigate through financial and regulatory hurdles.

Visa Completes Exchange Offer for Class B-1 Stock Confidently

Visa Completes Exchange Offer for Class B-1 Stock Confidently

Visa has successfully concluded its Exchange Offer for Class B-1 common stock, wrapping up the offer on May 6, 2024. The company announced the results following the offer's expiration on May 3, 2024. Notably, approximately 98% of outstanding Class B-1 shares participated, amounting to 240,677,470 shares, according to Visa's announcements. In the exchange, Visa issued 120,338,683 shares of Class B-2 common stock while also providing 47,759,832 shares of Class C common stock. Cash was offered in lieu of fractional shares, based on the closing price of Class A common stock, which was $268.49 on the expiration date. Crucially, Visa opted not to engage in any stabilization or manipulation of share prices during this offer period, as reported by contracts.justia.com. This strategic financial maneuver by Visa aimed to unlock liquidity for its shareholders by releasing transfer restrictions on its Class B stock. By doing so, Visa not only potentially reduces overhang risks but also showcases its ongoing commitment to market stability and reinforcing shareholder trust.